CAS 110429-45-3
:13-bromo-2,5,8,11-tetraoxatridecane
Description:
13-Bromo-2,5,8,11-tetraoxatridecane is a synthetic organic compound characterized by its unique structure, which includes a long carbon chain with multiple ether linkages and a bromine substituent. The presence of four ether groups (–O–) in its structure contributes to its solubility in polar solvents and may influence its reactivity and stability. The bromine atom introduces a halogen functionality, which can enhance the compound's reactivity, particularly in nucleophilic substitution reactions. This compound is likely to exhibit properties typical of polyether compounds, such as low volatility and potential applications in materials science or as intermediates in organic synthesis. Its molecular structure suggests that it may have interesting interactions with biological systems, although specific biological activity would require further investigation. Overall, 13-bromo-2,5,8,11-tetraoxatridecane represents a class of compounds that can be explored for various chemical applications, including potential uses in pharmaceuticals or as functional materials.
Formula:C9H19BrO4
InChI:InChI=1/C9H19BrO4/c1-11-4-5-13-8-9-14-7-6-12-3-2-10/h2-9H2,1H3
SMILES:COCCOCCOCCOCCBr
Synonyms:- 2,5,8,11-Tetraoxatridecane, 13-Bromo-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
Triethylene Glycol 2-Bromoethyl Methyl Ether
CAS:Formula:C9H19BrO4Purity:>95.0%(GC)Color and Shape:White to Yellow to Green clear liquidMolecular weight:271.15Triethylene Glycol 2-Bromoethyl Methyl Ether
CAS:Formula:C9H19BrO4Purity:95%Color and Shape:LiquidMolecular weight:271.1488m-PEG4-Br
CAS:<p>m-PEG4-Br is an ADC linker for Trastuzumab, altering hydrophilicity and potency, placed away from MMAE.</p>Formula:C9H19BrO4Purity:98%Color and Shape:SolidMolecular weight:271.15
